Trial intelligence / Profile preview

Naropin versus Marcaine pudendal nerve block for pain control after open haemorrhoidectomy

ACTRN12612000126819Phase 4Withdrawn

Sponsor
Gold Coast University Hospital
Start
Feb 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in hemorrhoid comparing Naropin pudendal nerve block with Marcaine pudendal nerve block (2 arms). Primary endpoint: Effectiveness of two local anaesthetic agents for pudendal nerve block. Planned start Feb 2012; status: withdrawn.

02

Drugs

ropivacainebupivacaine
03

Conditions

hemorrhoid

Beyond the preview

Go deeper on ACTRN12612000126819.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612000126819.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call